• Lifeward Ltd LFWD.OQ reported a quarterly adjusted loss of 62 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -91 cents. The mean expectation of three analysts for the quarter was for a loss of 51 cents per share. Wall Street expected results to range from $-1.10 to -20 cents per share.

• Revenue rose 9.6% to $7.55 million from a year ago; analysts expected $7.84 million.

• Lifeward Ltd's reported EPS for the quarter was a loss of $1.73​.

• The company reported a quarterly loss of $15.28 million.

• Lifeward Ltd shares had fallen by 8.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 80.1% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Lifeward Ltd is $10.00

This summary was machine generated from LSEG data March 7 at 03:11 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)